Sandra J. Horning - Concepedia

Author

Sandra J. Horning

Also Known As

Horning, Sandra J, S HORNING, S Horning, S J Horning, S. Horning, S. J. Horning, S.J. Horning, SANDRA J. HORNING, SJ Horning, Sandra Horning

307

Publications

32.3K

Citations

H-Index

122

Concepts

All Affiliations

Stanford University BC Cancer Agency Stanford Medicine Dana-Farber Cancer Institute University of Wisconsin–Madison

About

Sandra J. Horning is an author at Stanford University specializing in medicine, oncology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	34	54	7.3K
2	Health Sciences	19	21	1.8K
3	Engineering	1	1	60
4	Humanities	1	1	22
5	Nursing	1	1	42

Sandra J. Horning

153

Publications

27.4K

Citations

H-Index

Page 1

	Year	Citations
Revised Response Criteria for Malignant Lymphoma Bruce D. Cheson, Beate Pfistner, Malik E. Juweid, Journal of Clinical Oncology	2007	4.4K
A predictive model for aggressive non-Hodgkin's lymphoma Margaret A. Shipp, David P. Harrington, J R Anderson, Lymphoid NeoplasiaAggressive Non-hodgkinMedicinePathologyLymphatic Disease	1993	3.5K
A Prognostic Score for Advanced Hodgkin's Disease Dirk Hasenclever, Volker Diehl, Jamés O. Armitage, New England Journal of Medicine	1998	1.7K
Rituximab-CHOP Versus CHOP Alone or With Maintenance Rituximab in Older Patients With Diffuse Large B-Cell Lymphoma Thomas M. Habermann, Edie Weller, Vicki A. Morrison, Journal of Clinical Oncology	2006	1.4K
Impact of Cancer-Related Fatigue on the Lives of Patients: New Findings From the Fatigue Coalition Gregory A. Curt, William Breitbart, David Cella, The Oncologist	2000	1.2K
The Natural History of Initially Untreated Low-Grade Non-Hodgkin's Lymphomas Sandra J. Horning, Saul A. Rosenberg New England Journal of Medicine	1984	907
Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. The Fatigue Coalition. Nicholas J. Vogelzang, William Breitbart, David Cella, PubMed	1997	771
Prognostic significance of actual dose intensity in diffuse large-cell lymphoma: results of a tree-structured survival analysis. Larry W. Kwak, Jerry Halpern, Richard A. Olshen, Journal of Clinical Oncology PrognosisPathologyDose IntensityPrognostic SignificancePharmacotherapy	1990	433
ABVD Alone versus Radiation-Based Therapy in Limited-Stage Hodgkin's Lymphoma Ralph M. Meyer, Mary Gospodarowicz, Joseph M. Connors, New England Journal of Medicine	2011	404
Recombinant Leukocyte A Interferon: Pharmacokinetics, Single-Dose Tolerance, and Biologic Effects in Cancer Patients Jordan U. Gutterman, Seymour Fine, Jorge R. Quesada, Annals of Internal Medicine Single-dose ToleranceImmunologyPathologyCancer PatientsImmunotherapy	1982	378

Page 1